In 2020, chronically ill patients with Medicare Advantage have the possibility of accessing a broader range of supplemental benefits that might not be health-related but could help improve or maintain the health or overall function of the enrollees. The benefits address the social determinants of health.

For example, for patients with asthma, the plan could cover home air cleaners and carpet shampooing to reduce irritants that could trigger asthma attacks. The plan could provide heart healthy food and produce for patients with heart disease and could provide transportation to a doctor’s appointment, education program or to see a nutritionist for patients with diabetes.

CMS encourages Medicare Advantage plans to take advantage of new cost sharing reductions for patients with chronic pain or that are undergoing addiction treatment and for Part D plans to provide at least one opioid-reversal agent on a lower cost-sharing tier.

The agency is also taking steps to advance Medicare Part D opioid-related measures through the development of the star ratings process. The specifications have been updated for the use of opioids at high dosage and/or from multiple providers, and concurrent use of opioids and benzodiazepines measures, and have been added to the display page.

CMS’ policies have resulted in a 14 percent decrease in the share of Part D beneficiaries using opioid between 2010 and 2016.

“(Yesterday’s) changes give plans the ability to be innovative and (offer) benefits and services that address social determinants of health for people with chronic disease,” said Verma.

Inside Digital Health™ delivers the information that healthcare decision makers and physicians need to confidently navigate the digital transformation. We bring you compelling stories about the institutions and individuals who are fomenting positive change — so you can join them in leveraging the tools of healthcare technology and leading the noble quest toward improving patient care and eliminating healthcare waste.